Troy Bryenton - 11 May 2023 Form 3 Insider Report for Science 37 Holdings, Inc.

Role
Chief Technology Officer
Signature
/s/ Christine Pellizzari, Attorney-in-Fact for Troy Bryenton
Issuer symbol
N/A
Transactions as of
11 May 2023
Net transactions value
$0
Form type
3
Filing time
12 May 2023, 16:19:12 UTC
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding SNCE Restricted Stock Units 11 May 2023 Common Stock 250,000 Direct F1, F2
holding SNCE Restricted Stock Units 11 May 2023 Common Stock 522,793 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On October 7, 2022, Mr. Bryenton received restricted stock units representing 250,000 shares subject to a three-year vesting schedule, vesting 33 1/3% on the first, second and third anniversaries of the grant date. As restricted stock units vest, the vested units are automatically converted to vested common stock on a one-for-one basis on the vesting date.
F2 Each restricted stock unit represents a contingent right to receive one share of Science 37 Holdings, Inc.'s common stock.
F3 On March 10, 2023, Mr. Bryenton received restricted stock units representing 522,793 shares subject to a three-year vesting schedule, vesting 33 1/3% on the first, second and third anniversaries of the grant date. As restricted stock units vest, the vested units are automatically converted to vested common stock on a one-for-one basis on the vesting date.